October 09, 2009
Hiberix Haemophilus influenzae type b (Hib) vaccine available
With the availability of Hiberix, the increased supply of Hib vaccines will be sufficient to support a provider-initiated notification process to contact all children whose Hib booster dose had been deferred during the supply shortage of Hib vaccines in the U.S. In response, the CDC's Advisory Committee on Immunization Practices (ACIP) has provided updated recommendations for Hib booster vaccination. The recommendations may be found at www.cdc.gov/mmwr/preview/mmwrhtml/mm5836a5.htm.
For more information call (888) 825-5249 or visit www.hiberix.com.